Sign in
4

Changes in Ownership

TREACE MEDICAL CONCEPTS, INC. Filed Acc 0000950170-25-097601

Chief Innovation Officer acquired 33,437 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Scanlan Sean F. · Chief Innovation Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-07-18 Exercise or conversion : show line 1 in the form +33,437 $0.72 $24,001 383,621 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-07-18 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −33,437 0 D
Loading xslF345X05/ownership.xml…